JUBLIA 10 %
EFINACONAZOLE : 10 % · DIN 02413388 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is JUBLIA?
JUBLIA 10 % contains EFINACONAZOLE : 10 %. It is listed in the Health Canada Drug Product Database under DIN 02413388, held by BAUSCH HEALTH, CANADA INC., supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as marketed, status dated 21-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JUBLIA used for?
Topical treatment of mild to moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to Trichophyton rubrum and Trichophyton mentagrophytes in immunocompetent adults.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02413388 |
|---|---|
| Brand name | JUBLIA |
| Generic / active ingredient | EFINACONAZOLE : 10 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 10 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D01AC19 EFINACONAZOLE |
| AHFS class | 28:08.92 ; 12:12.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Jan-2020 |
How is it administered?
Apply once daily (preferably at bedtime) to affected toenails using the built-in brush. A second application should be done onto the affected big toenail(s). Clean and dry nails before use.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-30°C). Keep bottle tightly closed and store in an upright position.
How is it supplied?
White plastic bottle with built-in flow-through brush applicator. Each bottle contains 8 mL of solution.
Contraindications
Known hypersensitivity to efinaconazole or to any of the excipients of JUBLIA or component of the container.
Warnings and precautions
Not for ophthalmic, oral, or intravaginal use. Flammable; keep away from heat or flame. Discontinue if severe irritation occurs. Not studied in immunocompromised patients or those with diabetes.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.